Skip to main content
Defiance International

The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.

In vitro record. OncoTargets and therapy, 2025.

  • Cell
  • 2025

Authorship

Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.

Source: the abstract of PMID 40955371. Checked Verification: Evidence verified by machine against declared source

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

Evidence verified by machine against declared source

Open declared source

Key facts

Design
Not reported
System
Cell
Scale
Not published. Nothing is shown here and nothing is substituted for it.
Comparator
None reported
Journal
OncoTargets and therapy
Year
2025
PMID
40955371
Verification
Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Abstract only

Technical summary

Outcomes examined

Cell proliferation was assessed after treatments with scalar doses of Tα1 in tumor cMM (ie, Mel146, Mel195, Mel261, Mel514, Mel599, and Mel601), GBM (ie, LN-18, DBTRG-05MG, SiGBM56, and SiGBM71), and PM (ie, Meso4, Meso6, and Meso7) cell lines (1 µM, 10 µM, 100 µM) and in HD’s immune cell subsets (30 nM, 300 nM, 3 µM), by the WST-1 assay (Roche, Molecular Biochemicals, Mannheim, Germany).

Not reported in the declared source: Methods, Key findings. Not published in this record: Research question, Study design, Participants or experimental system, Study scale, Intervention or exposure, Comparator, Key findings.

Limitations and uncertainty

Not published. Nothing is shown here and nothing is substituted for it.

Cite

Cite the study

The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.
Solmonese L, Lofiego MF, Fazio C et al. OncoTargets and therapy. 2025. PMID 40955371. DOI 10.2147/ott.s527785

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.